Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.83USD
12 Dec 2017
Change (% chg)

$-0.06 (-2.08%)
Prev Close
$2.89
Open
$2.89
Day's High
$2.89
Day's Low
$2.75
Volume
97,863
Avg. Vol
145,722
52-wk High
$6.48
52-wk Low
$2.24

Select another date:

Wed, Nov 8 2017

BRIEF-Ophthotech Q3 earnings per share $5.25

* Ophthotech reports third quarter 2017 financial and operating results

BRIEF-Ophthotech recieves termination notice from Novartis Pharma

* Ophthotech-On oct 24, co received from Novartis Pharma notice terminating Licensing & Commercialization Agreement between parties dated May 19, 2014 Source text : (http://bit.ly/2gPty5O) Further company coverage:

BRIEF-Ophthotech gives update on programs for treatment of eye diseases

* Ophthotech provides update on Zimura® complement programs for treatment of eye diseases

BRIEF-Ophthotech reports second quarter 2017 financial and operating results

* Q2 earnings per share view $1.05 -- Thomson Reuters I/B/E/S

BRIEF-Ophthotech expands focus with development for ophthalmic orphan diseases

* Ophthotech expands focus with development for ophthalmic orphan diseases

BRIEF-Ophthotech and Novartis Pharma enters into a letter agreement with respect to licensing and commercialization agreement

* Ophthotech - on July 3, co and Novartis Pharma entered into a letter agreement with respect to licensing and commercialization agreement dated May 19, 2014

Select another date: